SB 1052
Initials PRB Page 1 Transmitted
ARIZONA HOUSE OF REPRESENTATIVES
Fifty-sixth Legislature
First Regular Session
Senate: COM DPA/SE 6-0-1-0 | 3
rd
Read 23-6-1-0
House: COM DP 9-0-0-1 | 3
rd
Read 47-12-1-0
SB 1052: insurance coverage; biomarker testing
Sponsor: Senator Shope, LD 16
Transmitted to the Governor
Overview
Excludes a policy that provides limited benefit coverage from the requirement that the policy
provide coverage for biomarker testing.
History
Contracts for health services, evidence of coverage for health care plans and health insurance
policies issued by a hospital or medical service corporations, health care services organization,
disability insurer or group or blanket disability insurer are statutorily required to provide coverage
for biomarker testing. Biomarker testing is the analysis of a patient's tissue, blood or other
biospecimen for the presence of a biomarker. A biomarker is a characteristic that is objectively
measured and evaluated as an indicator of normal biological processes, pathogenic processes
or pharmacologic responses to a specific therapeutic intervention (A.R.S. §§ 20-841.13, 20-
1057.19, 20-1376.10 and 20-1406.10).
Statute defines limited benefit coverage as an insurance policy that is designed, advertised and
marketed to supplement major medical insurance and that includes accident only, dental only,
vision only, disability income only, fixed or hospital indemnity, specified disease insurance, credit
insurance or Taft-Hartley trusts (A.R.S. § 20-1137).
Provisions
1. Specifies a policy that is issued or renewed by a disability insurer, or a group or blanket
disability insurer does not include a policy that provides limited benefit coverage. (Sec. 1, 2)
2. Makes a clarifying change. (Sec. 1, 2)
☐ Prop 105 (45 votes) ☐ Prop 108 (40 votes) ☐ Emergency (40 votes) ☐ Fiscal Note